Search for: "GLAXOSMITHKLINE"
Results 21 - 40
of 1,808
Sort by Relevance
|
Sort by Date
15 May 2023, 8:13 am
GlaxoSmithKline LLC, and in some ways the only positive outcome is that the Court has shown it is willing to refuse to take action is cases other than subject matter eligibility (although Justice Kavanaugh indicated he would have granted the petition). [read post]
15 May 2023, 7:21 am
GlaxoSmithKline LLC. [read post]
14 May 2023, 9:48 pm
Sanofi"; "GlaxoSmithKline Files Amicus Brief in Amgen v. [read post]
11 May 2023, 9:11 pm
Sanofi"; "GlaxoSmithKline Files Amicus Brief in Amgen v. [read post]
11 May 2023, 1:16 pm
GlaxoSmithKline LLC. [read post]
8 May 2023, 8:43 pm
Sanofi"; "GlaxoSmithKline Files Amicus Brief in Amgen v. [read post]
1 May 2023, 10:11 am
GlaxoSmithKline LLC, No. 22-37: This case examines whether FDA-required labeling in a “skinny-label” situation can be considered patent infringement. [read post]
6 Apr 2023, 6:38 am
The judge reviewed the national case law on selections/deletions from multiple lists (Merck v Shionogi [2016] EWHC 2989 (Pat), Nokia v IPCom [2012] EWCA Civ 567 and GlaxoSmithKline v Wyeth [2016] EWHC 1045 (Pat)) and the EPO cases reviewed therein and in the EPO Case Law Book. [read post]
23 Mar 2023, 5:32 am
As an example, it can be a sign of infringement if the marketing strategy induces doctors to prescribe the generic for the omitted therapeutic indication (GlaxoSmithKline v. [read post]
19 Mar 2023, 9:32 pm
By Kevin E. [read post]
15 Feb 2023, 2:01 pm
GlaxoSmithKline(GSK), the maker of Zantac, a medication commonly used to decrease stomach acid production, was warned by its own scientists and independent researchers about a potential cancer-causing impurity, according to reports by Businessweek. [read post]
15 Feb 2023, 2:01 pm
GlaxoSmithKline(GSK), the maker of Zantac, a medication commonly used to decrease stomach acid production, was warned by its own scientists and independent researchers about a potential cancer-causing impurity, according to reports by Businessweek. [read post]
21 Jan 2023, 6:07 pm
Steven Nissen, on the supposed risk of heart attack from the use of rosiglitazone (Avandia).[2] Within days, lawsuits were filed against the manufacturer, GlaxoSmithKline, which ultimately paid over six billion dollars in settlements and costs.[3] Only after the harm of this mass tort was largely complete, the results of a mega-trial, RECORD,[4] became available, and the FDA changed its regulatory stance on rosiglitazone.[5] More recently, on October 17, 2022, the Journal of the National… [read post]
5 Jan 2023, 3:45 pm
So naturally, GlaxoSmithKline tried to figure out other ways to increase their market share for Zofran. [read post]
22 Dec 2022, 10:14 am
Further, therein, it is reported that GlaxoSmithKline Inc. has updated the Canadian product monograph for Valtrex to add information about the risk of Valtrex-associated DRESS. [read post]
22 Dec 2022, 7:59 am
GlaxoSmithKline LLC, No. 22-37, has a good chance of being heard by the Court, although it may be better for Congress to work to resolve the pending questions. [read post]
1 Dec 2022, 11:16 am
GlaxoSmithKline PLC, 2022 WL 17338047, No. 21-CV-4869 (GRB)(AYS) (E.D.N.Y. [read post]
4 Nov 2022, 3:49 pm
I don’t think that Amgen and GlaxoSmithKline are overstating the case. [read post]
4 Nov 2022, 3:49 pm
I don’t think that Amgen and GlaxoSmithKline are overstating the case. [read post]
17 Oct 2022, 11:27 am
Glaxosmithkline LLC, 981 F.3d 1030, 1040 (Fed. [read post]
